| |
|
|
Session 52
Poster Presentations HIV Vaccines Using Viral Vectors Thursday 1:30 - 3:30 pm Hall D |
| 435 | Using Immunostimulatory Cytokines Delivered by rSV40 Vectors to Generate Powerful and Long-lasting Cell-mediated Immune Responses Against HIV Envelope gp120 H. J. McKee*, D. S. Strayer Jefferson Med Coll, Philadelphia, PA |
| 436 | Immunization Against SIV Gag Using Recombinant SV40 Vectors Elicits Strong, Durable Cell-mediated Immune Responses H. J. McKee*, D. S. Strayer Jefferson Med Coll, Philadelphia, PA |
| 437 | Construction and Characterization of Herpes Simplex Virus-derived AIDS Vaccine Vectors M. Brockman*, D. Watanabe, L. Mathews, D. Knipe Harvard Med Sch, Boston, MA |
| 438 | Intranasal Vaccine Subunit Priming Followed by MVA Boosting Enhances the Induction of HIV-specific IFN J. Peacock*1, S. Nordone1, S. Jackson2, H-X. Liao1, N. Letvin2, A. Gomez-Yafal3, L. Gritz3, G. Mazzara3, B. Haynes1, H. Staats1 1Duke Univ Med Ctr, Durham, NC; 2Beth Israel Deaconess Med Ctr, Boston, MA; and 3Therion Biologics Corp, Cambridge, MA |
| 439 | Towards Better Strategies for Poxvirus-based HIV Vaccines: Studies of the Cellular Tropism of Modified Vaccinia Ankara and Vaccinia Virus in Primary Human Cells A. Chahroudi*1, R. Chavan1, L. Liu2, E. K. Waller1, G. Silvestri1, M. B. Feinberg1 1Emory Univ, Atlanta, GA and 2Harvard Univ, Cambridge, MA |
| 440 | Design, Construction, and Testing of a Multi-valent Recombinant Modified Vaccinia Ankara Vaccine for Use Against the Dominant Circulating C/B Recombinant Form of HIV-1 in China Z. Chen*1,2, Y. Huang1,2, X. Zhao1,2, L. Ba1,2, W. Zhang1,2, Y. Song1,2, D. Gurner1,2, D. D.Ho1,2 1Aaron Diamond AIDS Res Ctr, New York, NY and 2The Rockefeller Univ, New York, NY |
| 441 | Efficient Human Immunodeficiency Virus-like Particles Formation from a Single Semliki Forest Virus Replicon E. Kim*, H. J. Shin, K. S. Shin, H. S. Kim, C. J. Kim Coll of Veterinary Med, Chungnam Natl Univ, Soeul, Korea |
| 442 | A Novel Adenovirus Recombinant Vaccine to HIV-1 A. R. Pinto*, G. Gao, J. M. Wilson , H. C. J. Ertl Wistar Inst, Philadelphia, PA |
| 443 | Longitudinal Analysis of Vaccinated Macaques after Partial Control of Primary SIVmac239 Infections T. Matano2, W. Lun1, M. Kano1, A. Takeda1, H. Nakamura1, K. Mori1, T. Sata1, Y. Nagai3, W. Sugiura*1 1Natl Inst of Infectious Diseases, Tokyo, Japan; 2Univ of Tokyo, Japan; and 3Toyama Inst of Hlth, Japan |
| 444 | SIV Promoter Exchange Results in a Highly Attenuated Strain that Strongly Protects Against Pathogenic Challenge Virus P. Blancou*1,2, N. Chenciner2, R. Ho Tsong Fang3, V. Monceaux3, M-C. Cumont3, D. Guetard2, B. Hurtrel3, S. Wain-Hobson2 1Harvard Univ, Boston, MA; 2URM Inst Pasteur, Paris, France; and 3PIL Inst Pasteur, Paris, France |
| 445 | Innate and Adaptive Immune Responses to Infection of Macaques with Pathogenic and Attenuated SIV Strains P. N. Fultz*1, Q. Wei1, B. Tao1, P. Vance2, J. Lifson3, M. Piatak3, J. A. Hoxie2 1Univ of Alabama at Birmingham; 2Univ of Pennsylvania, Philadelphia; and 3Natl Cancer Inst, Frederick Cancer Res Devel Ctr, Frederick, MD |
| 446 | Molecular Biology and Immunobiology of Infection with a Replication Incompetent HIV-1 Bin Wang*1, Wayne Dyer2, John Zaunders3, Anthony Kelleher3, John Sullivan2, Nitin Saksena1 1Westmead Hosp, Sydney, Australia; 2Australian Red Cross Blood Svc, Sydney, Australia; and 3St Vincent's Hosp, Sydney, Australia |